Edesa Biotech, Inc.
EDSA
$2.43
$0.010.41%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.90M | 3.97M | 3.86M | 4.13M | 4.65M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.45M | 6.47M | 7.06M | 7.01M | 8.38M |
| Operating Income | -6.45M | -6.47M | -7.06M | -7.01M | -8.38M |
| Income Before Tax | -5.92M | -5.84M | -6.11M | -6.17M | -6.93M |
| Income Tax Expenses | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 |
| Earnings from Continuing Operations | -5.92 | -5.84 | -6.11 | -6.17 | -6.93 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.92M | -5.84M | -6.11M | -6.17M | -6.93M |
| EBIT | -6.45M | -6.47M | -7.06M | -7.01M | -8.38M |
| EBITDA | -6.32M | -6.33M | -6.89M | -6.85M | -8.21M |
| EPS Basic | -1.33 | -1.60 | -1.88 | -1.93 | -2.21 |
| Normalized Basic EPS | -0.92 | -1.11 | -1.35 | -1.35 | -1.63 |
| EPS Diluted | -1.33 | -1.60 | -1.88 | -1.93 | -2.21 |
| Normalized Diluted EPS | -0.92 | -1.11 | -1.35 | -1.35 | -1.63 |
| Average Basic Shares Outstanding | 18.92M | 15.12M | 13.01M | 12.79M | 12.57M |
| Average Diluted Shares Outstanding | 18.92M | 15.12M | 13.01M | 12.79M | 12.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |